Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03287687 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of CO2 for Endoscopy
A Phase 4 study, sponsored by Warren Bishop.
- Completed
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
NCT03287687: Completed Phase 4 study, sponsored by Warren Bishop.
NCT03287687 is a Phase 4 study that has completed, run by Warren Bishop. The registered enrollment target is 180 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03287687, a Phase 4 study, has completed, sponsored by Warren Bishop.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
Study Summary
Hypothesis: Carbon dioxide gas use for endoscopic insufflation is safe and results in less abdominal distension and discomfort; it is equally effective as air in pediatric patients undergoing endoscopic procedures. Aim 1: Determine the occurrence and severity of abdominal discomfort and distension associated with endoscopic procedures at baseline, upon awakening from anesthesia, at discharge and at 4 hours after discharge in carbon dioxide group when compared to the air group. Aim 2: Determine if the expertise level of the endoscopist contributes to abdominal discomfort and distension following endoscopy, and whether this differs in the carbon dioxide group versus air group. Aim 3: Determine if carbon dioxide is as effective as air for insufflation.
Primary Outcome
Change in abdominal girth from baseline to end of procedure (Time Difference 1) or Change in abdominal girth from baseline to time of discharge ((Time Difference 2)
Interventions
- DRUG Carbon dioxide (CO2) gas insufflation
- DRUG Air insufflation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2019-04-09 |
| Phase | Phase 4 |
What the finished NCT03287687 record still lists
NCT03287687 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 2 interventions - of which Carbon dioxide (CO2) gas insufflation is the first listed.
NCT03287687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03287687 about?
NCT03287687 is a clinical study titled "Safety and Efficacy of CO2 for Endoscopy". Hypothesis: Carbon dioxide gas use for endoscopic insufflation is safe and results in less abdominal distension and discomfort; it is equally effective as air in pediatric patients undergoing endoscopic procedures. Aim 1: Determine the occurrence and severity of abdominal discomfort and distensio...
What is the current status of trial NCT03287687?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2017-11-27. Estimated completion is 2019-04-09.
What interventions are being tested in trial NCT03287687?
The interventions under investigation include: Carbon dioxide (CO2) gas insufflation (DRUG), Air insufflation (DRUG).
Who is sponsoring clinical trial NCT03287687?
This trial is sponsored by Warren Bishop, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03287687's enrollment target sits among peer trials
180 466th of 2000 higher than 1,525 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI